Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chubb
Julphar
Daiichi Sankyo
McKinsey
Healthtrust
Deloitte
Johnson and Johnson
Merck
Baxter

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075331

« Back to Dashboard

NDA 075331 describes DIFLORASONE DIACETATE, which is a drug marketed by Fougera Pharms, Taro, Akorn, and Riconpharma Llc, and is included in seven NDAs. It is available from seven suppliers. Additional details are available on the DIFLORASONE DIACETATE profile page.

The generic ingredient in DIFLORASONE DIACETATE is diflorasone diacetate. There are three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the diflorasone diacetate profile page.
Summary for 075331
Pharmacology for NDA: 075331
Suppliers and Packaging for NDA: 075331
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIFLORASONE DIACETATE diflorasone diacetate OINTMENT;TOPICAL 075331 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1295 51672-1295-1 1 TUBE in 1 CARTON (51672-1295-1) > 15 g in 1 TUBE
DIFLORASONE DIACETATE diflorasone diacetate OINTMENT;TOPICAL 075331 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1295 51672-1295-2 1 TUBE in 1 CARTON (51672-1295-2) > 30 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.05%
Approval Date:May 14, 1999TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Medtronic
Julphar
Healthtrust
Baxter
Daiichi Sankyo
Cipla
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot